Mito Metabolism targets the mitochondria; the organelles responsible for generating virtually all of the body's usable energy. When mitochondrial function declines through oxidative damage, membrane deterioration, or coenzyme depletion, the downstream effects include persistent fatigue, cognitive sluggishness, and reduced metabolic efficiency. SS-31 and NAD+ address the two primary mechanisms underlying this decline: membrane structural integrity and the coenzyme availability that drives energy production.
SS-31 is a mitochondria-targeted antioxidant tetrapeptide with a unique ability to selectively accumulate within the inner mitochondrial membrane. Its mechanism centers on binding to cardiolipin; a phospholipid found almost exclusively in the inner mitochondrial membrane that is essential to the function of the electron transport chain complexes responsible for ATP synthesis. Oxidative stress damages cardiolipin, disrupting the structural architecture of the inner membrane and reducing the efficiency of electron transfer and energy production.
SS-31 protects cardiolipin from this oxidative damage, preserving the membrane's integrity and the efficiency of the mitochondrial machinery it supports. This cardiolipin-protective mechanism also underlies SS-31's cardioprotective and neuroprotective properties; cardiac and neuronal cells have the highest mitochondrial density in the body and are most vulnerable to mitochondrial dysfunction.
NAD+ provides the electron-carrying capacity that the electron transport chain requires to convert nutrients into ATP. Within the context of Mito Metabolism, its role is specifically to ensure that the restored mitochondrial architecture supported by SS-31 has the coenzyme substrate it needs to operate at full capacity.
NAD+ also activates sirtuins; a class of proteins that regulate mitochondrial biogenesis, the process by which cells generate new mitochondria, and that modulate the oxidative stress responses operating alongside SS-31's protective mechanism. The two compounds are mutually reinforcing: SS-31 preserves the mitochondrial structure, NAD+ fuels it.
Mito Metabolism is administered as a subcutaneous injection five mornings per week over a five or ten-week program. Your RegenMD provider establishes dosing based on your metabolic profile and wellness goals, and monitors your response throughout.
What This Means For You
- Sustained cellular energy without crash
- Preserves mitochondrial structural integrity through cardiolipin protection
- Reduces oxidative stress at the mitochondrial level
- Optimizes ATP production efficiency
- Cardioprotective and neuroprotective support
- Improved mental clarity and focus
- Activates sirtuins to drive cellular repair
- Promotes long-term metabolic health